AstraZeneca Pharma hits 52-week high on delisting plan
Shares of drug maker AstraZeneca Pharma India surged 20 per cent, hitting 52-week high, in early trade on Bombay Stock Exchange (BSE) on reports that parent company AstraZeneca Pharmaceuticals AB suggested that it plans to delist company's equity shares from the Indian stock exchanges.
Cheering the news, shares of company rallied as much as 20 per cent to trade at Rs 1110.90 a piece on the BSE.
In a similar fashion, shares of the company advanced 20 per cent to Rs 1,112.90 a piece on National Stock Exchange. Meanwhile, the broader benchmark Sensex was quoting at 21,100.07, down 20.05 points or 0.09 per cent at 9:45 hours.